Compound Information | SONAR Target prediction | Name: | NADPH tetrasodium | Unique Identifier: | LOPAC 00455 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | C21H26N7Na4O17P3 | Molecular Weight: | 807.142 g/mol | X log p: | 5.025 (online calculus) | Lipinksi Failures | 3 | TPSA | 288.89 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 24 | Rotatable Bond Count: | 13 | Canonical Smiles: | [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OC1C(O)C(COP([O-])(=O)OP([O-])( =O)OCC2OC(C(O)C2O)N2C=CCC(=C2)C(N)=O)OC1n1cnc2c(N)ncnc12 | Class: | Nitric Oxide | Action: | Cofactor | Generic_name: | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUC | Chemical_iupac_name: | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDEPHOSPHATE | Drug_type: | Experimental | Drugbank_id: | EXPT02321 | Drug_category: | Pteridine Reductase inhibitor | Organisms_affected: | -1 |
Species: |
4932 |
Condition: |
DEP1 |
Replicates: |
2 |
Raw OD Value: r im |
0.5950±0.00806102 |
Normalized OD Score: sc h |
1.0009±0.000934163 |
Z-Score: |
0.0356±0.0367321 |
p-Value: |
0.971616 |
Z-Factor: |
-39.917 |
Fitness Defect: |
0.0288 |
Bioactivity Statement: |
Nonactive |
Experimental Conditions | | Library: | Lopac | Plate Number and Position: | 11|H9 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 26.90 Celcius | Date: | 2005-11-16 YYYY-MM-DD | Plate CH Control (+): | 0.039925±0.00166 | Plate DMSO Control (-): | 0.58195±0.01274 | Plate Z-Factor: | 0.9242 |
| png ps pdf |
15983949 |
1-[(2R,3R,4S,5R)-5-[[[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonatooxy-oxolan-2-yl]methox y-oxido-phosphoryl]oxy-oxido-phosphoryl]oxymethyl]-3,4-dihydroxy-oxolan-2-yl]-4H-pyridine-3-carboxamide |
internal high similarity DBLink | Rows returned: 0 | |
active | Cluster 306 | Additional Members: 11 | Rows returned: 0 | |
|